02.01 Safety and efficacy of ocrelizumab in rheumatoid arthritis patients with an inadequate response to methotrexate or tumour necrosis factor inhibitors: A systematic review and meta-analysis

Hussien Ahmed; Abdelrahman Ibrahim Abushouk; Ammar Ismail; Ahmed Elmaraezy; Ahmed Said Badr; Mohamed Gadelkarim; Mohammed Elnenny

doi:10.1136/annrheumdis-2016-211050.1

Article info

New players and novel targets in inflammation

02.01 Safety and efficacy of ocrelizumab in rheumatoid arthritis patients with an inadequate response to methotrexate or tumour necrosis factor inhibitors: A systematic review and meta-analysis

Authors

Hussien Ahmed 1Faculty of Medicine, Zagazig University, El Sharkia, Egypt2Student Research Unit, Zagazig University, El Sharkia, Egypt3Medical Research Group of Egypt, Cairo, Egypt PubMed articles Google scholar articles
Abdelrahman Ibrahim Abushouk 3Medical Research Group of Egypt, Cairo, Egypt4Faculty of Medicine, Ain shams University, Cairo, Egypt5NovaMed Medical Research Association, Cairo, Egypt PubMed articles Google scholar articles
Ammar Ismail 3Medical Research Group of Egypt, Cairo, Egypt5NovaMed Medical Research Association, Cairo, Egypt PubMed articles Google scholar articles
Ahmed Elmaraezy 3Medical Research Group of Egypt, Cairo, Egypt6Faculty of Medicine, Al Azhar University, Cairo, Egypt PubMed articles Google scholar articles
Ahmed Said Badr 3Medical Research Group of Egypt, Cairo, Egypt6Faculty of Medicine, Al Azhar University, Cairo, Egypt7Faculty of Medicine, Menoufia University, Menoufia, Egypt PubMed articles Google scholar articles
Mohamed Gadelkarim 3Medical Research Group of Egypt, Cairo, Egypt9Faculty of Medicine, Alexandria University, Alexandria, Egypt PubMed articles Google scholar articles
Mohammed Elnenny 3Medical Research Group of Egypt, Cairo, Egypt6Faculty of Medicine, Al Azhar University, Cairo, Egypt PubMed articles Google scholar articles

Citation

Ahmed H, Abushouk AI, Ismail A, et al

02.01 Safety and efficacy of ocrelizumab in rheumatoid arthritis patients with an inadequate response to methotrexate or tumour necrosis factor inhibitors: A systematic review and meta-analysis

Annals of the Rheumatic Diseases 2017;76:A8.

Publication history

First published March 1, 2017.

Online issue publication

January 09, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password